Journal article
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes mellitus. Dr. Hertzel Gerstein in an interview with Dr. Roman Jaeschke.
Authors
Gerstein H; Jaeschke R
Journal
Polish Archives of Internal Medicine, Vol. 126, No. 10, pp. 803–805
Publisher
"Medycyna Praktyczna" Spolka Jawna
Publication Date
October 28, 2016
DOI
10.20452/pamw.3612
ISSN
0032-3772